Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Kilpatrick

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Pharmacoepidemiology and Drug Safety|June 8, 2012
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisionsRyan D Kilpatrick, Dave Gilbertson, M Alan Brookhart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2013
Trends in hip fracture rates in US hemodialysis patients, 1993-2010Thomas J Arneson, Shuling Li, Jiannong Liu, et al.
Expert Opinion on Drug Safety|July 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilanceInyoung Lee, Todd A Lee, Stephanie Y Crawford, et al.
Therapeutic Innovation & Regulatory Science|July 29, 2020
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in PharmacovigilanceInyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, et al.
RMD Open|November 2, 2019
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world settingHuifang Liang, Raghava Danwada, Dianlin Guo, et al.
Journal of the American Society of Nephrology : JASN|June 8, 2013
Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patientsAnne C Beaubrun, Ryan D Kilpatrick, Janet K Freburger, et al.
International Journal of Cardiology|June 6, 2013
Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION studyAlain Cohen-Solal, Steven J Keteyian, John R Horton, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2006
Association between serum lipids and survival in hemodialysis patients and impact of raceRyan D Kilpatrick, Charles J McAllister, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 18, 2008
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patientsRyan D Kilpatrick, Cathy W Critchlow, Steven Fishbane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 16, 2005
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fractionKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Noriko Kuwae, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|June 8, 2012
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisionsRyan D Kilpatrick, Dave Gilbertson, M Alan Brookhart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2013
Trends in hip fracture rates in US hemodialysis patients, 1993-2010Thomas J Arneson, Shuling Li, Jiannong Liu, et al.
Expert Opinion on Drug Safety|July 15, 2020
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilanceInyoung Lee, Todd A Lee, Stephanie Y Crawford, et al.
Therapeutic Innovation & Regulatory Science|July 29, 2020
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in PharmacovigilanceInyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, et al.
RMD Open|November 2, 2019
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world settingHuifang Liang, Raghava Danwada, Dianlin Guo, et al.
Journal of the American Society of Nephrology : JASN|June 8, 2013
Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patientsAnne C Beaubrun, Ryan D Kilpatrick, Janet K Freburger, et al.
International Journal of Cardiology|June 6, 2013
Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION studyAlain Cohen-Solal, Steven J Keteyian, John R Horton, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2006
Association between serum lipids and survival in hemodialysis patients and impact of raceRyan D Kilpatrick, Charles J McAllister, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 18, 2008
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patientsRyan D Kilpatrick, Cathy W Critchlow, Steven Fishbane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 16, 2005
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fractionKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Noriko Kuwae, et al.
Pageof 5